Posters
Accepted Posters
First Day – 26 Feb 2025 (9:00 – 2:00)
Posters will be evaluated by the scientific committee from 9:00 to 11:00
- Corporate Criminal Liability for Fraudulent or Harmful Vaccine Manufacturing: A Legal Analysis
- Principles of Transparency and Accountability in Legal Governance Frameworks of the Biopharmaceutical Industry
- Assessment of Monoclonal Antibodies Handling Practices and Regulatory Needs in Saudi Healthcare Settings
- Hay Fever Vaccine Using Oak Tree Pollen
- Possible Therapeutic Applications of Larinus Maculates F.: in-Vitro Biological Approaches of its Methanolic Extracts
- Isolation and Characterization of Bacteriophages from Wastewater in The Makkah Region for Therapeutic Applications
- Iron-Gold Nanohybrids for Cancer Immunotherapy
- Recent Advancements In Alzheimer's Disease Treatment: Molecular Docking And ADME Profiles Of Lycorine As A Potential Natural Therapy Compared To Galantamine
- The Peaks in Gram Negatives during COVID-19 and Their rapid decline Post-Vaccinations implied Potential Evolution of Co-Protection in COVID-19 vaccines
- Mohamed Fathi Shehta Diab
- Dr. Gamal Sayed Khalifa Mohamed
- Moayad Alhejazi
- Omar Mansour
- Amjad alshammari
- Malak Albeladi
- Dr. Mariam Abdulaziz
- Haya A. Albakr
- Mohammed Al-Ghozwi
Second Day – 27 Feb 2025 (9:00 – 2:00)
Posters will be evaluated by the scientific committee from 9:00 to 11:00
- Chemical Composition, Antibacterial Activity and In Vitro Anticancer Evaluation of Ochradenus baccatus Methanolic Extract
- The identification of Superficial fungal infection in high-risk population using molecular methods
- Chemical investigation and possible therapeutic effects of Juniperus Horizontalis Extracts
- Phytochemical Screening and Biological Activities of Convolvulus oxyphyllus Extracts
- Salvadora persica as a Poteintial Chemopreventative Agent Against Bone and Skin cancer
- Perceptions and preferences of the Saudi Arabia population regarding telehealth services: A cross-sectional study
- Therapeutic effects of apitoxin (bee venom) nanocoating and polyvinyl alcohol enhanced with zinc oxide nanoparticles
- Characteristics of studies conducted in Saudi Arabia and submitted in the United
- Biochanin A ameliorates doxorubicin-induced cardiac injury in rats via modulation of PI3K/AKT/ m-TOR axis
- Enas Alrkad
- Saadia Yassin alsomali
- Tahani Mishaal Alshammari
- Rawan Salem Alshammari
- Alanoud Suliman Ayesh
- Enas Alrkad
- Shahad F. Alharbi
- Ibrahim M. Alsultan
- Mashael M. Almutairi
We invite experts and researchers in the biological drugs vaccines and all related fields
To submit abstracts for presentations at the conference This is
A great opportunity to share your research findings and innovations with a global audience
Submission Guidelines: [click here for submit abstracts]
Contact Us
For any inquiries regarding the conference,
please feel free to reach out to us at:
Cphar@uoh.edu.sa